Contract Pharmacal Corp. Expands Campus in Hauppauge, New York
09/21/2018
According to the Suffolk County Industrial Association, the company plans to acquire and connect a 17,500 square foot manufacturing complex next to its current facility on Oser Avenue.
Suffolk County IDA is offering incentives to assist the firm that develops, produces and packages pharmaceuticals with its expansion, and enable it to expand its workforce by an estimated 150 associates.
IDA incentives include granting the firm sales tax cuts and about $3.6 million in property tax abatements over 20 years. Incentives cannot be used by the firm to acquire its new building complex.
“The proposed investment will help expand Contract Pharmacal’s manufacturing operations in Suffolk County and add a significant number of jobs to the local economy,” said Tony Catapano, Executive Director of the Suffolk County IDA.
“This project is critical to our overall operations and ability to remain competitive in the global marketplace,” Mark Wolf, Contract Pharmacal's President, said in press release.
Project Announcements
M&H Valve Expands Anniston, Alabama, Production Operations
03/31/2026
Toyota Motor Manufacturing Kentucky Expands Georgetown, Kentucky, EV Vehicle Production Operations
03/31/2026
Indra Group Plans Olathe, Kansas, Operations
03/31/2026
Phos Window Expands Fort Payne, Alabama, Production Operations
03/31/2026
International Paper Expands Rankin County, Mississippi, Operations
03/31/2026
Construction Partners Plans Dothan, Alabama, Headquarters Operations
03/25/2026
Most Read
-
Top States for Doing Business in 2024: A Continued Legacy of Excellence
Q3 2024
-
Economic Developer Role Shifting from Deal-Making to Systems Stewardship
Q1 2026
-
What Companies Need from Modern Manufacturing Sites
Q1 2026
-
Capitalizing on the OBBBA Before the 2026 Cliff
Q1 2026
-
Last Word: Don’t Lose by Winning
Q1 2026
-
Advanced Manufacturing Isn’t a Buzzword—It’s a Different Location Strategy
Q1 2026
-
The Geography of Packaging: Why Location Strategy Matters More Than Ever
Q1 2026